Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Kindred Biosciences, Inc. (KIN)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-21Mar-31-21Jun-30-20Mar-31-20Dec-31-19Sep-30-19Jun-30-19Mar-31-19
   10-Q10-Q10-Q10-Q10-K10-Q10-Q10-Q
Net income    -29.7-68.1-61.4-61.1-58.8-55.8
Depreciation and amortization   [+]  3.73.12.52.01.61.2
Asset impairment charges     3.5    
Stock-based compensation    7.67.67.47.37.16.6
Change in working capital   [+]  -2.4-0.8-4.7-3.5-6.6-4.3
Other operating activities    0.0-0.1-0.2-0.2-0.2-0.2
Cash from operations    -17.4-54.8-56.3-55.5-57.0-52.5
   
Capital expenditures   [+]  -4.7-7.2-8.4-12.7-18.2-16.2
Purchases of short-term investments, net    -2.6-12.7-39.4-26.3-22.7-0.8
Cash from investing    -7.3-19.9-47.8-39.0-40.9-16.7
   
Issuance of common stock, net         92.3
Option exercises    1.11.52.01.91.81.5
Other cash from financing    20.721.522.722.53.12.5
Cash from financing    19.620.063.863.744.493.3
   
Free cash flow    -22.1-62.0-64.8-68.2-75.2-68.6
        Per share (diluted)    ($0.56)($1.59)($1.68)($1.86)($2.13)($2.10)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy